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Abstract. The genomic surveillance of porcine reproductive and respiratory syndrome virus 
(PRRSV) is based on sequencing of the ORF5 gene of the virus, which covers only 4% of the 
entire viral genome. It is expected that PRRSV whole-genome sequencing (WGS) will improve 
PRRSV genomic data and allow better understanding of clinical discrepancies observed in the 
field when using ORF5 sequencing. Our main objective was to implement an efficient method 
for WGS of PRRSV from clinical samples. The viral genome was purified using a poly(A)-tail 
viral genome purification method and sequenced using Illumina technology. We tested 149 
PRRSV-positive samples: 80 sera, 33 lungs, 33 pools of tissues, 2 oral fluids, and 1 processing 
fluid (i.e., castration liquid). Overall, WGS of 67.1% of PRRSV-positive cases was successful. 
The viral load, in particular for tissues, had a major impact on the PRRSV WGS success rate. 
Serum was the most efficient type of sample to conduct PRRSV WGS poly(A)-tail assays, with a 
success rate of 76.3%, and this result can be explained by improved sequencing reads dispersion 
matching throughout the entire viral genome. WGS was unsuccessful for all pools of tissue and 
lung samples with Cq values >26.5, whereas it could still be successful with sera at Cq ≤34.1. 
Evaluation of results of highly qualified personnel confirmed that laboratory skills could affect 
PRRSV WGS efficiency. Oral fluid samples seem very promising and merit further investigation 
because, with only 2 samples of low viral load (Cq = 28.8, 32.8), PRRSV WGS was successful.
Key words: animal viral disease; MiSeq; poly(A)-tails; porcine reproductive and respiratory 
syndrome virus; swine virus; whole-genome sequencing.
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Introduction
Porcine reproductive and respiratory syndrome (PRRS) is an important viral disease causing 
severe economic losses in North America, with estimated losses of $663 million and $150 
million per year in the United States and Canada, respectively.19,35 Therefore, considerable effort 
and resources are allocated to attempt to control and contain the virus. Among those efforts, 
biosecurity measures, vaccination, and epidemiologic surveillance are the most prominent.29,37 
The disease has many clinical manifestations, but the 2 most common are reproductive disorders 
in sows and gilts (characterized by late abortions with an increased number of stillbirths and 
mummified fetuses, including weak-born piglets)4,7,21,30,41 and respiratory problems in pigs of all 
ages (characterized by interstitial pneumonia).1,4,8,15,41
PRRS virus (PRRSV; Nidovirales, Arteriviridae, Betaarterivirus suid), the etiologic 
agent of PRRS,22,34 is an enveloped virus of 50–65 nm diameter.44 The PRRSV genome is 
composed of a positive single-stranded RNA of ~15 kb nucleotides (nt), and it encodes at least 
11 open reading frames (ORFs).32 Approximately three-quarters of the genome is composed of 
ORF1 at the 5’-end of the genome, which encodes for nonstructural proteins; the ORFs located at 
the 3’-end (ORF2–7) encode mostly for virion structural proteins.10,20,34 Moreover, its viral 
genome extremities are capped at the 5’-end, and with a polyadenylated tail (poly(A)-tail) at the 
3’-end.10,20 The pathogenicity of PRRSV is multigenic, whereas several lineages of PRRSV exist 
within both PRRSV species (i.e. Betaarterivirus suid 1 and 2, commonly named PRRSV types 1 
and 2 or PRRSV-1 and -2, respectively) and, consequently, the virulence of the strains is variable 
(from low to high).34 Molecular epidemiologic tools have been developed to help in the control 
of PRRSV and to understand the links between a specific PRRSV strain with: 1) the origin of an 
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outbreak, and 2) its genetic proximity with vaccine strains, to estimate their potential efficacy.25-
27
The ORF5 gene of PRRSV has been selected for the epidemiologic surveillance of 
PRRSV strains because: 1) it is hypervariable,27,40 and 2) it encodes a protein (GP5) that induces 
the synthesis of neutralizing antibodies in pigs.13,39 This GP5 antigenicity property has 
contributed to the selection of ORF5 for PRRSV surveillance despite the fact that other viral 
proteins are involved in the neutralizing antibody recognition of the virion.6 Most reported 
studies have used ORF5 for the classification of PRRSV.27 Moreover, ORF5 sequencing is part 
of the strategy that has been put in place to control PRRSV.25,26 As an example, with the 
agreement of all of the swine veterinarians in the province of Québec (Canada), the Molecular 
diagnostic laboratory (MDL) of the Service de diagnostic, Faculté de médecine vétérinaire 
(FMV), Université de Montréal (UdeM), is the depository of a databank containing almost all 
PRRSV ORF5 nt sequences that have been sequenced since ~2010. This agreement has set up 
the rules for data sharing between veterinarians. To date, at least 4,695 PRRSV ORF5 nt 
sequences are included in this databank. Noteworthy, some researchers have recently reported 
that 11% of the PRRSV strains were misclassified by the ORF5 sequencing method (i.e., PCR 
amplification of the ORF5 gene followed by the sequencing of ORF5 PCR amplicons by the 
Sanger-based sequencing method) compared to PRRSV whole-genome sequencing (WGS), 
because of viral genome recombination events and simultaneous coinfection of 2 significantly 
different PRRSV strains in some swine clinical samples.24 Thus, the ORF5 genomic 
methodology that is currently used can cause classification errors and therefore mislead 
veterinary interventions.
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Over the past few years, next-generation sequencing (NGS) has been a very powerful tool 
for the detection and discovery of viruses in a large diversity of environments, sample types, and 
hosts.9,12,14,18 In fact, NGS has allowed the discovery and sequencing of the entire viral genome 
of new swine viruses, such as the atypical porcine pestivirus and porcine circovirus 3.16,38 
Therefore, there is an urge to improve the present ORF5 molecular epidemiologic tool for the 
surveillance of PRRSV through the use of NGS tools. During the last North American PRRS 
Symposium and Conference of Research Workers in Animal Diseases (CRWAD) joint meeting 
(Nov 2019, Chicago, IL: https://vetmed.illinois.edu/vet-resources/continuing-education/north-
american-prrs-symposium/, https://crwad.org/crwad2019/), several speakers reported the WGS 
of PRRSV using different technologies, such as MiSeq (Illumina) and MinION (Oxford 
Nanopore Technologies). Unfortunately, a lack of data was obvious regarding the efficacy of 
those WGS methods with various swine clinical samples.
Therefore, we implemented an efficient method for WGS of PRRSV from different types 
of swine clinical samples that are routinely submitted for diagnostic and surveillance purposes, 
allowing its use in a real veterinary diagnostic laboratory environment.
Materials and methods
Swine clinical samples
Convenience swine clinical samples that tested positive for PRRSV by a reverse-transcription 
quantitative PCR (RT-qPCR) assay were selected for WGS with the goal of obtaining the entire 
PRRSV viral genome. The clinical samples were submitted between December 2015 and July 
2019; most were collected in 2017 (n = 43) and 2018 (n = 46). The samples were mainly tested 
by the MDL using a PRRSV RT-qPCR assay for the identification of PRRSV after an outbreak 
of the disease in swine herds, and to a lesser extent to conduct surveillance of the virus in herds. 
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Four clinical samples were confirmed to be PRRSV positive by another veterinary diagnostic 
laboratory (Biovet, St-Hyacinthe, Québec, Canada). The swine clinical samples originated from 
different swine herds and types of production systems throughout the province of Quebec, 
Canada.
We included 149 PRRSV RT-qPCR–positive clinical samples: 80 sera (of which 48 
samples are pooled sera), 33 lung tissues, 2 oral fluids (OF), and 1 processing fluid (PF; i.e., in 
our case, fluid from testes after castration; Table 1). An additional category of clinical samples 
was obtained from pathologists conducting carcass macroscopic examinations and submitted as a 
pool of tissues (PoT), including mainly lungs with several other types of tissues such as lymph 
nodes, spleen, liver, and intestine (Table 1). We included 33 PRRSV RT-qPCR–positive PoT 
clinical samples. The PRRSV RT-qPCR assay cycle quantification (Cq) values of all clinical 
samples were 11.5–34.3 (mean: 22.6 ± 4.5). More specifically, the mean Cq values of specific 
types of clinical samples were: 22.4 ± 3.9, 22.3 ± 4.5, 22.5 ± 4.6, 30.8 ± 2.8, and 28.9 (only 1 
sample) for lung, PoT, sera, OF, and PF, respectively.
PRRSV RT-qPCR assay
The PRRSV RT-qPCR assay conducted by the MDL (American Association of Veterinary 
Laboratory Diagnosticians [AAVLD] accredited) was an in-house assay (protocol PON-MOL-
029). Briefly, PRRSV RNA was isolated from clinical samples (QIAamp cador pathogen mini 
kit, Qiagen; KingFisher Flex automated nucleic acid extraction apparatus, Thermo Fisher 
Scientific) as recommended by the manufacturers. Thereafter, 5 μL of RNA was used to conduct 
RT-qPCR assays (Rotor-Gene real-time PCR; Qiagen). The primers and probe sequences of the 
PRRSV RT-qPCR assay cannot be disclosed because they are the property of MDL. Noteworthy, 
a log-linear equation to quantify the amount of PRRSV genome copies per mL or gram of 
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clinical samples was established using a standard curve determined with commercial standards 
(Tetracore). The equation was established as follow: y = 10(-0.307x + 10.390) × 100; y = number of 
viral genome copies, x = RT-qPCR Cq value, and 100 = RNA elution volume in μL.
Genome extraction and purification
We ground 100 mg of lung or tissues (Beadbeater; BioSpec Products) in phosphate-buffered 
saline, then centrifuged at full speed for 1 min and used the supernatant for viral extraction. Two 
hundred µL of sera, OF, and PF were centrifuged for 5 min at 10,000 × g, and the supernatant 
was used for viral extraction. Viral RNA was extracted (Quick-RNA viral kit; Zymo Research) 
as described in the company’s protocol. Thereafter, RNA was eluted using 50 µL of nuclease-
free water (Corning). Total elution volume was used to isolate RNA with poly(A)-tails 
(NEBNext Poly(A) mRNA magnetic isolation module; New England BioLabs), as described in 
the company’s protocol, and poly(A)-tails RNA was resuspended in 15 µL of Tris buffer (New 
England BioLabs). Then, first-strand complementary DNA (cDNA) was synthesized (Non-
directional reaction step up protocol, NEBNext RNA first strand synthesis module; New England 
BioLabs), starting with 10 µL of isolated poly(A)-tails RNA. Immediately after first-strand 
cDNA synthesis, the second DNA strand was synthesized (NEBNext Ultra II non-directional 
RNA second strand synthesis module; New England BioLabs), as described by the 
manufacturer’s protocol with a minor modification at the incubation step in the thermocycler for 
2 h (instead of 1.5 h) at 16°C. Double-stranded DNA (dsDNA) was then purified (AxyPrep Mag 
PCR clean-up kits; Axygen Corning) using 1.8× of beads and 70% ethanol. The purified dsDNA 
was diluted in 30 µL of 10 mM Tris-HCl at pH 8.0 and was stored at –20°C.
PRRSV WGS
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Double-stranded DNA was quantified (Qubit dsDNA HS assay kit, Qubit fluorometer; Thermo 
Fisher Scientific). Sequencing libraries (Nextera XT DNA library preparation kit; Illumina) were 
still performed even when the dsDNA quantification results were lower than the Qubit dsDNA 
HS assay kit threshold of detection (0.2 ng). Briefly, 0.2–0.3 ng/µL of dsDNA was used to 
construct the sequencing libraries (5 µL total volume was used, even when dsDNA 
quantification results were below the threshold of detection). Fragmentation and tagmentation 
was performed as suggested by the manufacturer’s protocol. Amplification and indexation were 
also performed as described by the manufacturer’s protocol, except that 14 amplification cycles 
were run. Sequencing libraries were then purified (AxyPrep Mag PCR clean-up kits) as 
described in the Nextera XT protocol. Library quality was assessed (High sensitivity DNA kit, 
Bioanalyzer; Agilent). Sequencing libraries were normalized (LNB1 beads; Nextera XT 
protocol), or with the manual normalization protocol if the concentrations of the libraries were in 
the lower part of the Bioanalyzer curves. Sequencing libraries were sequenced in a v3 600-cycle 
cartridge using a MiSeq instrument, and PhiX was included at ~1% of the total sequencing 
libraries as a control to establish the sequencing run efficacy (Illumina). Variable numbers of 
PRRSV sequencing libraries were indexed per MiSeq run in consideration of the type of samples 
being sequenced. In fact, several types of samples obtained from different animal species were 
processed simultaneously by the high-throughput sequencing laboratory and were subsequently 
combined, to allow optimal use of the v3 600-cycle cartridges. Those samples may have 
included: 1) bacteria, 2) viruses contained within various clinical samples (or may have been 
previously isolated), and 3) PCR amplicons (for different purposes such as 16S microbiome 
characterization and swine influenza A virus sequencing). Large amounts of MiSeq high-
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throughput sequencing reads data were obtained from each successful PRRSV WGS case (Suppl. 
Table 1).
Highly qualified personnel for PRRSV WGS efficiency
During our study, 2 highly qualified personnel (HQP) constructed sequencing libraries from the 
PRRSV RT-qPCR–positive swine clinical samples. A total of 83 and 66 clinical samples were 
processed by HQP-1 and HQP-2, respectively. HQP-1 processed 19 lungs, 17 PoT, and 44 sera; 
HQP-2 processed 14 lungs, 16 PoT, and 36 sera. HQP-1 also processed the 2 OF and the only PF 
clinical sample. All clinical samples that were processed by both HQPs are distinct, meaning that 
a specific clinical sample was processed by only one HQP, with rare exceptions. Both HQPs 
followed the same PRRSV WGS protocol described above.
Bioinformatic analyses
At first, reads were trimmed for adaptors and quality by the MiSeq software during FastQ 
generation. Using CLC Genomic Workbench software (v.12.0.3; Qiagen), reads from each 
sample were mapped using the Map Reads to Reference application with default settings against 
a list of PRRSV full-length genomes obtained from GenBank and from the PRRSV nt sequences 
obtained by our laboratory. Thereafter, all reads from each sample were mapped against the 
closest PRRSV full-length genome in the list. Consensus sequences were extracted from 
alignments that had full-length coverage. Moreover, reads were trimmed again for quality and 
adaptors using the CLC Genomic Workbench software (usually only a few reads, but some 
needed more trimming). This second step of trimming is highly recommended by Qiagen before 
doing de novo analysis. Then, de novo analysis was performed using the application “De novo 
Assemble Metagenome” with 2,000 minimum contigs length with the scaffolding settings 
option. Contigs were used to confirm the PRRSV full-length genome obtained by re-sequencing.
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Reads dispersion
A typical MiSeq sequencing experiment involves fragmentation of the genome to be sequenced 
from a clinical sample into millions of molecules. The set of fragments, after different 
modifications, is referred to as a sequencing library, which is sequenced to produce a set of reads 
(a read length depends on the protocol and may vary 100–300 bp; BREDA Genetics. Sequencing 
library: what is it? 2016. Accessed 2019 Dec 17: https://bredagenetics.com/sequencing-library-
cosa-e/). To calculate the reads dispersion throughout the entire viral genome (a critical step that 
is needed to ensure the efficiency of PRRSV WGS), the viral genome was divided into 2 
sections: 1) the 5’-region of the viral genome containing the ORF1 gene and that represents 
~75% of the entire viral genome; and 2) the 3’-region of the viral genome containing all other 
genes (ORF2–7). The number of reads targeting each genomic region was determined, including 
the overlapping reads that were included in both genomic regions. The ratio of reads was 
calculated as follow: 5’ viral genome-specific reads/3’ viral genome-specific reads. The higher 
the ratio of reads value, the higher the reads dispersion is expected throughout the viral genome.
Amount of PRRSV-specific reads
The % of PRRSV-specific reads per clinical sample was calculated as follows: (number of 
PRRSV-specific reads/total reads) × 100%.
Statistical analyses
All statistical analyses were performed using Prism software (v.8.3.0; GraphPad). Different types 
of analyses were performed, including parametric 2-tailed unpaired t tests, ordinary 1-way 
ANOVA with Tukey post-tests, and ordinary 2-way ANOVA.
Results
Page 10 of 39Journal of Veterinary Diagnostic Investigation
For Peer Review
Page 11 of 28
Complete PRRSV genome sequences (Table 1) were obtained from 100 samples (67.1%; Fig. 1). 
More interestingly, the WGS success rate was more efficient with sera (76.3%) compared to 
lungs (60.6%) and PoT (51.5) clinical samples (Fig. 1). Noteworthy, OF and PF samples were 
not included in the statistical analyses because of the low number of samples (i.e., 2 OF and 1 
PF). Nonetheless, WGS sequences of PRRSV were obtained from both OF samples, whereas the 
PRRSV entire viral genome was not obtained from PF.
One hypothesis was that the WGS success rate is highly dependent on the viral load. To 
test this hypothesis and to establish the efficiency of the poly(A)-tail method for PRRSV WGS, it 
was essential to compare the WGS success rate with PRRSV viral load in each clinical sample. 
The success of PRRSV WGS from clinical samples was significantly higher with a higher viral 
load (i.e., lower PRRSV RT-qPCR Cq values; Fig. 2) for all types of samples (i.e., lungs, PoT 
and sera; p < 0.0001; 2-way ANOVA). Therefore, as expected, 100% PRRSV WGS-positive 
results were obtained for all types of clinical samples at the higher viral load (i.e., ≤15 Cq, which 
is the lower PRRSV RT-qPCR Cq value).
Moreover, the WGS success rate was also dependent on the type of samples being 
analyzed (p = 0.004; 2-way ANOVA). In fact, PRRSV WGS was more successful from sera, 
with 75.4% to 72.4% WGS-positive results, for Cq values of ≤25 and ≤35, respectively (Fig. 2). 
The type of clinical samples from which WGS was less successful was PoT with 66.7% to 54.8% 
WGS-positive results, for Cq values of ≤25 and ≤35, respectively (Fig. 2). The overall WGS 
success % (i.e., at Cq ≤35) for all clinical samples with known Cq values was 65.2% (Fig. 2). 
The viral load of each clinical sample was plotted and separated into 2 groups (i.e., the samples 
from which WGS-positive and -negative results were obtained; Fig. 3). WGS-positive results 
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were obtained with tissues (i.e., lungs and PoT) for up to the lower viral load of 26.5 Cq, 
whereas for sera, the lower viral load with a WGS-positive result was 34.1 Cq (Fig. 3).
Interesting results were obtained with OF regarding PRRSV WGS sensitivity. Although 
only 2 OF samples were tested, with 28.8 and 32.8 Cq values, respectively, WGS-positive results 
were obtained for both samples (data not shown), whereas the higher Cq values obtained with 
lungs and PoT were 26.5 and 26.0, respectively. Unfortunately, the only PF clinical sample 
tested (with 28.9 Cq value) was WGS negative (data not shown). The viral loads of WGS-
positive results were significantly different compared to WGS-negative results for 2 types of 
samples in addition to all of the samples (Fig. 3). More precisely, the viral loads for WGS-
positive and -negative cases in all samples were 21.6 ± 4.2 and 24.4 ± 4.5 (p < 0.001); in lungs, 
20.9 ± 2.9 and 24.6 ± 4.1 (p < 0.01); and, in PoT, 20.7 ± 3.4 and 24.4 ± 4.6 (p < 0.05), 
respectively (Fig. 3). Interestingly, the viral loads in sera were not significantly different when 
WGS-positive and -negative results groups were compared (Fig. 3).
The efficiency and sensitivity of WGS of a virus from a clinical sample is highly 
dependent on the number of target-specific reads obtained during a NGS run and on the viral 
load contained in the clinical sample. Therefore, we evaluated and compared the % of PRRSV-
specific reads obtained from clinical samples to PRRSV viral loads contained within WGS-
positive and -negative samples (Fig. 4). Overall, the % of PRRSV-specific reads was higher in 
sera at all viral loads compared to lungs and PoT clinical samples (Fig. 4B–D). Noteworthy, the 
number of PRRSV-specific reads did not correlate with the PoT sample viral loads (Fig. 4C). 
PoT PRRSV-specific reads were very low compared to sera and lung PRRSV-specific reads. 
Noteworthy, PoT sample composition may differ because the pooled samples contained various 
amounts of different swine tissues and subsequently, may also have contained various amounts 
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of high-throughput sequencing inhibitors. This could explain why no correlation was found 
between the viral loads and PRRSV-specific reads for PoT samples.
The synthesis of sequencing libraries is a critical phase that may fail at different steps 
along their construction. Therefore, sequencing libraries need HQP to ensure the validity of NGS 
results. Consequently, we evaluated HQP efficiency (Fig. 5). Before comparing the WGS results 
between HQPs, it was essential to determine if the clinical sample viral loads were similar 
between the samples tested by each HQP. Noteworthy, the viral load of the clinical samples 
tested by HQP-2 was significantly higher than the viral load of clinical samples tested by HQP-1 
(21.6 ± 3.9 vs. 23.4 ± 4.8, respectively; Fig. 5A; p = 0.022). Surprisingly, even if HQP-2 had 
tested samples with lower Cq values, their PRRSV WGS success rate was overall lower 
compared to HQP-1 (p = 0.021; Fig. 5B). In fact, the % of PRRSV WGS-positive results for all 
samples, lungs, PoT, and sera were: 78.3% and 53.0%; 79.0% and 35.7%; 58.8% and 43.8%; and 
86.4% and 63.9% for HQP-1 and -2, respectively (Fig. 5B). As expected, clinical sample PRRSV 
Cq values were significantly lower in PRRSV WGS-positive cases compared to WGS-negative 
cases for both HQP (Fig. 5C).
In order to obtain the complete viral genome sequence of PRRSV directly from a clinical 
sample, it is necessary to ensure good dispersion of PRRSV-specific reads throughout the entire 
viral genome. Therefore, we calculated ORF1/ORF2–7 reads ratios to estimate the reads 
dispersion throughout the entire viral genome. Surprisingly, almost opposite results were 
obtained by both HQPs (Fig. 6). The reads dispersion was significantly higher in sera compared 
to lung clinical samples as expected for HQP-1 (p = 0.020; 1.61 ± 0.56 vs. 1.21 ± 0.54, 
respectively), whereas the reads dispersion seems to be higher in lungs compared to serum 
clinical samples for HQP-2 (1.20 ± 0.50 vs. 0.82 ± 0.87, respectively), but both sample groups 
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were not significantly different (p = 0.359; Fig. 6). When reads dispersion results of both HQPs 
were combined, no statistical difference was found between serum and lung clinical samples (p = 
0.459). An example of HQP-1 reads dispersion obtained with a serum and a lung sample is 
illustrated in Fig. 6B.
Discussion
Based on previous reports, it was obvious that NGS of the PRRSV genome from clinical samples 
needed to be improved significantly.17,45,48 In fact, in one research report, the metagenomic 
approach that was proposed to sequence PRRSV genome, which was based on Illumina 
technology, was unsuccessful with nasal swabs (PRRSV RT-qPCR Cq values of 25–35) and OF 
(PRRSV RT-qPCR Cq values of 20–29).17 The authors suggested that these types of samples 
were not appropriate because of the low viral load, viral genome degradation, and competition 
for sequencing reads given that several other viral and bacterial genome sequences were found 
using their metagenomics approach, in particularly in OF. Unfortunately, in our study, no nasal 
swabs were included in the analyses, therefore no comparison can be made. Noteworthy, WGS 
of PRRSV was successful with the 2 tested OF samples even if the PRRSV viral load was lower 
in one sample (PRRSV RT-qPCR Cq values of 28.8 and 32.8), indicating that the poly(A)-tail 
approach, to increase the specific selection of PRRSV genome, has a great impact on the 
sensitivity of the method.
The metagenomic method that had been proposed17 was successful for PRRSV WGS 
with sera in 38.6% of the tested samples (PRRSV RT-qPCR Cq values of 14–25)17; whereas we 
achieved a success rate of 76.2%., illustrating the significant improvement that has been brought 
about by the poly(A)-tail method. Using a similar Illumina metagenomic method,17 with the 
addition of cDNA synthesis using random primers (hexamers), others have reported the ability to 
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generate PRRSV sequences by WGS from different types of clinical samples, but they were 
successful only with clinical samples containing higher viral loads compared to our study.48 They 
reported PRRSV WGS to be successful only from sera with PRRSV RT-qPCR Cq ≤23.6 
(whereas in the present study: Cq ≤34.1); successful only from lung tissues with Cq ≤21 
(whereas in the present study: Cq ≤26.5); and successful only from OF with Cq ≤20.6 (whereas 
in the present study: Cq ≤32.8),48 clearly illustrating that the poly(A)-tail method improves the 
sensitivity of PRRSV WGS.
In addition to MiSeq technology, others have reported the use of the Oxford Nanopore 
MinION direct RNA sequencing to generate PRRSV whole-genome sequences.45 Unfortunately, 
in that report, only 6 swine clinical samples (all sera) were tested, reducing the statistical 
significance and impact of their results for field application. Moreover, the sensitivity of the 
Oxford Nanopore MinION PRRSV WGS with these clinical serum samples was very low45 
compared to our study. The reported sensitivity with sera of the Oxford Nanopore technology 
was 4.65 × 104 times less compared to the MiSeq poly(A)-tail method (Oxford Nanopore 
sensitivity was 3.8 × 106 viral genome copies per sequencing reaction, and PRRSV WGS was 
unsuccessful, compared to 8.17 × 101 viral genome copies per sequencing reaction at 34.1 Cq 
value with the MiSeq poly(A)-tail method, and PRRSV WGS was successful). Other 
investigators have also reported the low sensitivity of the direct RNA sequencing method for 
WGS of several RNA viruses (with or without viral poly(A) tail genomes).46 Moreover, some 
concerns were raised regarding possible high sequence error rates of the direct RNA sequencing 
method of Oxford Nanopore technology that can limit virus strain identification.46 The low 
sensitivity of the Oxford Nanopore MinION direct RNA sequencing with swine clinical samples 
illustrates that further investigations are needed to improve this method.
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Our results demonstrate that PRRSV WGS is dependent on the viral load, a conclusion 
supported by other reports.17,48 Noteworthy, the viral load seems to have a negligible impact on 
PRRSV WGS success rate with sera (Fig. 3). Is it possible that other factors may influence the 
PRRSV WGS success rate with sera? Our study seems to support this hypothesis. In molecular 
testing, several PCR-inhibiting substances and factors may exist (such as proteases, calcium, 
iron, gel media, anticoagulants, degradation of the genomic content) in a clinical sample and 
need to be considered to ensure the quality of a result.47 The same inhibiting factors may have an 
impact on WGS success from a specific clinical sample. In fact, the PRRSV WGS poly(A)-tail 
method was unsuccessful with some clinical samples that possess a high viral load (e.g., serum at 
17.2 Cq and lung at 15.8 Cq), but overall, the number of PRRSV high-throughput sequencing 
reads was also higher in serum compared to lung samples at the same viral load.
It would have been interesting to determine from one individual infected pig, at different 
times post-infection, which is the most efficient type of sample to conduct PRRSV WGS. 
Unfortunately, our databank does not contain this type of sample to allow WGS efficiency 
comparison among samples of one infected individual. Nonetheless, we are confident that the 
obtained results indicate that serum is a very good sample choice to conduct PRRSV WGS.
Diverse genomes have been found by metagenomics in clinical samples (including host, 
bacterial, viral, and other high-throughput sequencing reads), and they are present in different 
ratios depending on the type of clinical sample being analyzed.36 Authors have reported that 
serum is the sample type with the highest ratio of reads related to viral genome (12%, whereas 
50% for host genome) compared to tissue (0.2%, whereas >95% for host genome).36 Therefore, it 
may explain why we found serum to be the most sensitive and appropriate type of sample to 
conduct PRRSV WGS assays, a finding also supported by 2 previous PRRSV WGS studies.17,48 
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It may also explain why the PRRSV WGS poly(A)-tail method, which allows the specific 
selection of the viral genome, may be more sensitive compared to MiSeq random primer 
approaches that will produce, in theory, a significantly larger quantity of indexed host genome.
The extracted RNA quality may have a major impact on PRRSV WGS efficiency. 
Unfortunately, the quantity of extracted and purified poly(A)-tail RNA from serum was too low 
to allow RNA quality assessment. In fact, it is possible to assess the RNA quality with a 
Bioanalyzer (Agilent) using a specific application (RNA integrity number, RIN). Unfortunately, 
RIN values are not accurate for samples that contain <25 ng RNA/μL.33 It is well known that the 
amount of extracted RNA from serum may be very low (i.e. 2–10 ng/μL),28,42 and therefore, we 
could not assess accurately the RIN value or RNA quality from serum in our study.
In theory, although PRRSV virions should be free in serum and therefore their viral 
genomes should not be in a replicative state, PRRSV viral genome in tissues may replicate in 
infected cells. During the viral genome replication of arteriviruses, a subset of viral subgenomic 
messenger RNA (i.e., poly(A)-tails mRNA) possessing the same 3’-end nucleotide sequences of 
the viral genome are synthesized.43 Consequently, the presence of viral subgenomic mRNA in 
infected tissues should increase the ORF2–7 viral gene copies (these ORFs are located at the 3’-
end of the viral genome) over the ORF1 viral gene copies and, therefore, reduce the 
ORF1/ORF2–7 read ratio. This phenomenon should subsequently decrease the high-throughput 
sequencing reads dispersion throughout the PRRSV viral genome from infected tissue in clinical 
samples. The results obtained by HQP-1 are in accordance with this theory, meaning that a better 
reads dispersion throughout the PRRSV genome was found with sera compared to lung samples. 
Unfortunately, opposite results regarding reads dispersion were obtained by HQP-2. This 
discrepancy may have arisen because the HQP-2 PRRSV WGS success rate was lower compared 
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to HQP-1 even if HQP-2 tested clinical samples possessing a higher viral load. Besides the fact 
that PCR-inhibiting factors may be present in a clinical sample, HQP skills to conduct high-
throughput sequencing laboratory handling are critical to ensure WGS assay success.
Several reports have described PRRSV WGS that were generated from viruses previously 
isolated in cell culture or from several PCR amplicons covering the entire viral genome.2,3,5,23 
Our goal was to implement a method that can efficiently work directly from clinical samples 
without virus isolation or prior PCR amplicon steps because some PCR amplicons could be 
missing, and because mutations and isolation of more specific PRRSV cell culture–adapted 
strains can be promoted.11,23,31 The poly(A)-tail viral genome purification method improved 
significantly the efficiency of PRRSV WGS from clinical samples compared to the methods that 
have been reported previously.17,45,48 Furthermore, serum was the most appropriate type of 
sample for sequencing the entire viral genome of PRRSV.
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Table 1. Porcine reproductive and respiratory syndrome virus (PRRSV) reverse-transcription 
quantitative PCR–positive sample description.
Whole-genome sequencing results
Success Failure
PRRSV-positive clinical samples tested (n) 100 49
% of PRRSV genome coverage 98–100 0–85
Mean coverage 9.85–49,314.88 0–4.84
% of PRRSV-specific reads 0.06–88.11 0.01–3.59
Type of sample tested   
Lungs 20 13
Pool of tissues 17 16
Processing fluid 0 1
Oral fluid 2 0
Sera 61 19
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Figure 1. Number of porcine reproductive and respiratory syndrome virus (PRRSV) 
whole-genome sequencing (WGS)-positive cases per type of clinical sample. PRRSV WGS was 
attempted only on PRRSV reverse-transcription quantitative PCR (RT-qPCR)-positive cases. 
The “all samples” group includes all types of samples that we tested (i.e., lungs, sera, OF, PF, 
and PoT). The number in boxes is the % of PRRSV WGS successful cases. OF = oral fluid; PF = 
processing fluid (i.e., castration liquid); PoT = pool of tissues; WGS (+) = PRRSV WGS 
success; WGS (–) = PRRSV WGS failure.
Figure 2. Percentage of PRRSV WGS success compared to sample viral load. The 
success of PRRSV WGS from clinical samples was significantly higher with a higher viral load. 
The “all samples” group includes all types of samples that we tested (i.e., lungs, sera, OF, PF, 
and PoT). Cq = cycle quantification. See Fig. 1 legend for other abbreviations.
Figure 3. PRRSV WGS success compared to sample viral load. The “all samples” group 
includes all types of samples that we tested (i.e., lungs, sera, OF, PF, and PoT). The bars and 
whiskers represent the PRRSV RT-qPCR Cq mean ± standard deviation; the empty dots 
represent individual Cq sample values. WGS (+) = PRRSV WGS success; WGS (–) = PRRSV 
WGS failure. WGS (+) and WGS (–) groups were compared by parametric 2-tailed unpaired t 
tests. * = p ≤ 0.05; ** = p ≤ 0.01; *** = p ≤ 0.001. See Fig. 1 legend for abbreviations.
Figure 4. Amount of PRRSV high-throughput sequencing–specific reads in clinical 
samples. Graphs were built with all clinical samples (i.e. from both WGS successful and 
unsuccessful samples). The bars and whiskers represent the % of PRRSV-specific reads mean ± 
standard error of the mean. Parametric ordinary 1-way ANOVA tests were done to compare the 
% of PRRSV-specific reads to the clinical sample viral load. A. all samples (including PF and 
OF); B. lung samples; C. PoT samples; and D. sera. The significant p values in graphs indicate 
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that the % of PRRSV-specific reads result is dependent on the viral load (i.e., PRRSV RT-qPCR 
Cq value). See Fig. 1 legend for abbreviations.
Figure 5. Highly qualified personnel (HQP) WGS efficiency. A. Viral load of PRRSV-
positive samples processed by both HQP. The whiskers go down to the smallest PRRSV RT-
qPCR Cq values and up to the highest Cq values; the box extends from the 25th to 75th 
percentiles. The bar within the box represents the median Cq values. Parametric 2-tailed 
unpaired t test was done to compare HQP-1 and HQP-2. * = p ≤ 0.05. B. Percentage of PRRSV 
WGS success for different types of samples for each HQP. The HQP effect on the results was 
determined using an ordinary 2-way ANOVA. C. The viral load (Cq values) of PRRSV WGS 
successful [WGS (+)] and unsuccessful [WGS (–)] samples per HQP was determined. The bars 
represent the Cq mean ± standard deviation. Parametric ordinary 1-way ANOVA with Tukey 
post-tests were done to compare each group. When 2 sets of data are labeled with superscripts of 
different letters or when only one set is labeled with a superscript letter, it indicates that these 2 
sets of data are statistically different (p ≤ 0.05). The Cq values of PRRSV WGS (+) samples 
were significantly different from WGS (–) samples for both HQP (* = p ≤ 0.05; ** = p ≤ 0.01). 
See Fig. 1 legend for other abbreviations.
Figure 6. PRRSV-specific reads dispersion throughout the viral genome. A. Open 
reading frame (ORF)1/ORF2–7 reads ratio obtained from WGS successful [WGS (+)] clinical 
samples. The bars and whiskers represent the ORF1/ORF2–7 reads ratio mean ± standard 
deviation. Parametric 2-tailed unpaired t tests were done to compare lungs and serum sample 
groups. * = p ≤ 0.05. B. Graphic representation of PRRSV genome nucleotide (nt) coverage, 
obtained after WGS of a lung and a serum sample by HQP-1. The nt coverage represent how 
many times a specific nt was sequenced following reads alignment to the viral genome. Two 
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samples with a similar range of coverage (up to 273 and 288 for the serum and lung samples, 
respectively) were selected. Green arrows represent ORF1–7 contained in the viral genome. See 
Fig. 1 legend for other abbreviations.
Supplementary Table 1.
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Figure 2. Percentage of PRRSV WGS success compared to sample viral load. The success of PRRSV WGS 
from clinical samples was significantly higher with a higher viral load. The “all samples” group includes all 
types of samples that we tested (i.e., lungs, sera, OF, PF, and PoT). Cq = cycle quantification. See Fig. 1 
legend for all other abbreviations. 
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Figure 3. PRRSV WGS success compared to sample viral load. The “all samples” group includes all types of 
samples that we tested (i.e., lungs, sera, OF, PF, and PoT). The bars and whiskers represent the PRRSV RT-
qPCR Cq mean ± standard deviation; the empty dots represent individual Cq sample values. WGS (+) = 
PRRSV WGS success; WGS (–) = PRRSV WGS failure. WGS (+) and WGS (–) groups were compared by 
parametric 2-tailed unpaired t tests. * = p ≤ 0.05; ** = p ≤ 0.01; *** = p ≤ 0.001. See Fig. 1 legend for 
abbreviations. 
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Figure 4. Amount of PRRSV high-throughput sequencing–specific reads in clinical samples. Graphs were 
built with all clinical samples (i.e., from both WGS successful and unsuccessful samples). The bars and 
whiskers represent the % of PRRSV-specific reads mean ± standard error of the mean. Parametric ordinary 
1-way ANOVA tests were done to compare the % of PRRSV-specific reads to the clinical sample viral load. A. 
all samples (including PF and OF); B. lung samples; C. PoT samples; and D. sera. The significant p values in 
graphs indicate that the % of PRRSV-specific reads result is dependent on the viral load (i.e., PRRSV RT-
qPCR Cq value). See Fig. 1 legend for abbreviations. 
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Figure 5. Highly qualified personnel (HQP) WGS efficiency. A. Viral load of PRRSV-positive samples 
processed by both HQP. The whiskers go down to the smallest PRRSV RT-qPCR Cq values and up to the 
highest Cq values; the box extends from the 25th to 75th percentiles. The bar within the box represents the 
median Cq values. Parametric 2-tailed unpaired t test was done to compare HQP-1 and HQP-2. * = p ≤ 
0.05. B. Percentage of PRRSV WGS success for different types of samples for each HQP. The HQP effect on 
the results was determined using an ordinary 2-way ANOVA. C. The viral load (Cq values) of PRRSV WGS 
successful [WGS (+)] and unsuccessful (WGS (–)] samples per HQP was determined. The bars represent the 
Cq mean ± standard deviation. Parametric ordinary 1-way ANOVA with Tukey post-tests were done to 
compare each group. When 2 sets of data are labeled with superscripts of different letters or when only one 
set is labeled with a superscript letter, it indicates that these 2 sets of data are statistically different (p ≤ 
0.05). The Cq values of PRRSV WGS (+) samples were significantly different from WGS (–) samples for both 
HQP (* = p ≤ 0.05; ** = p ≤ 0.01). See Fig. 1 legend for other abbreviations. 
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Figure 6. PRRSV-specific reads dispersion throughout the viral genome. A. Open reading frame 
(ORF)1/ORF2–7 reads ratio obtained from WGS successful [WGS (+)] clinical samples. The bars and 
whiskers represent the ORF1/ORF2–7 reads ratio mean ± standard deviation. Parametric 2-tailed unpaired t 
tests were done to compare lungs and serum sample groups. * = p ≤ 0.05. B. Graphic representation of 
PRRSV genome nucleotide (nt) coverage, obtained after WGS of a lung and a serum sample by HQP-1. The 
nt coverage represent how many times a specific nt was sequenced following reads alignment to the viral 
genome. Two samples with a similar range of coverage (up to 273 and 288 for the serum and lung samples, 
respectively) were selected. Green arrows represent ORF1–7 contained in the viral genome. See Fig. 1 
legend for all other abbreviations. 
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qPCR Cq value 
in a sample 
Type of 
sample 
No. of animals 
pooled in a 
sample Total reads 
No. of PRRSV 
mapped reads 




1844370 NA Serum 1 148,210 104,619 70.588 1,493 
1890826 21.98 Serum 1 2,073,558 1,386,641 66.873 19,809 
1926452 18.2 Lung 1 4,437,900 12,489 0.281 143 
1927781 23.74 Serum 1 935,500 28,537 3.050 364 
1943176 21.3 Sera 6 283,896 7,766 2.736 88 
1943177 14.5 Sera 6 1,738,040 1,080,360 62.160 15,185 
1943798 14.88 Sera 6 4,098,788 3,611,571 88.113 49,315 
1951167 22.75 Sera 7 3,257,468 1,268,970 38.956 17,111 
1952821 23.95 PoT 1 2,529,498 1,427 0.056 19 
1953024 21.68 Sera 7 467,026 75,971 16.267 839 
1953769 22.45 PoT 1 2,504,292 2,381 0.095 36 
1956308 20.17 PoT 1 1,664,089 14,931 0.897 204 
1957367 23.24 PoT 1 107,602 25,219 23.437 372 
1961450 24.42 Sera 5 1,452,828 173,038 11.910 2,561 
1961538 19.98 PoT 1 3,672,398 49,274 1.342 679 
1966315 20.08 Sera 4 344,968 49,276 14.284 478 
JVDI: Supplementary material 
Gagnon CA, et al. Porcine reproductive and respiratory syndrome virus whole-genome sequencing efficacy with field clinical samples 
using a poly(A)-tail viral genome purification method 
Supplementary Table 1. PRRSV WGS successful cases, high-throughput sequencing data. 
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1966316 18.48 Sera 4 1099770 44,7562 40.696 4,632 
1968868 34.13 Serum 1 1,543,552 2,504 0.162 35 
1968869 27.08 Serum 1 1,702,286 361,199 21.218 4,519 
1978525 21.79 Sera 8 171,332 48,987 28.592 482 
1980019 22.27 Lung 1 3,380,328 5,649 0.167 83 
1982018 21.15 Lung 1 1,925,924 27,669 1.437 381 
1982260 20.36 Sera 10 998,032 168,453 16.879 1,866 
1982353 18.19 Sera 6 1,437,798 1,147,565 79.814 13,678 
1982354 16.86 Sera 6 1,610,730 1,129,865 70.146 10,864 
1982412 13.89 Lung 1 1,888,322 481,256 25.486 6,805 
1985061 24.19 Lung 1 2,064,428 4,239 0.205 59 
1985928 15.25 Serum 1 35,366 10,304 29.135 126 
1994368 19.7 Lung 1 854,464 33,184 3.884 300 
2012512 17.94 Lung 1 1,427,924 247,213 17.313 3,210 
2013955 22.99 Lungs 2 1,730,426 12,038 0.696 164 
2016194 16.97 Lung 1 641,910 98,392 15.328 1,172 
2017769 22.23 Lungs 2 1,560,084 1,615 0.104 21 
2018110 21.85 Sera 5 3,772,466 3,280,540 86.960 37,953 
2018114 19.62 Sera 5 95,326 42,080 44.143 435 
2020590 24.59 PoT 1 1,464,302 3,552 0.243 46 
2021685 21.22 Lung 1 1,985,182 14,994 0.755 193 
2023030 18.73 Sera 3 684,202 487,383 71.234 5,096 
2023323 22.55 Lung 1 2,860,316 8,313 0.291 99 
2029734 21.85 Lung 1 1,536,754 2,059 0.134 25 
2035290 22.86 Sera 5 1,515,352 113,970 7.521 1,034 
2048380 20.23 Sera 10 1,156,950 52,039 4.498 495 
2050445 20.06 Serum 1 2,901,278 587,223 20.240 8,348 
Whole-genome sequencing of PRRSV
Gagnon CA, et al. Page 2 of 5 Suppl material
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2050887 23.52 Sera 10 893,244 22,467 2.515 230 
2057423 22.77 Sera 10 1,222,100 36,670 3.001 334 
2057984 24.4 Sera 5 175,942 40,968 23.285 53 
2058132 19.51 PoT 1 237,606 10,389 4.372 137 
2059368 18.09 Sera 10 129,220 60,072 46.488 758 
2059830 27.22 Sera 5 92,458 1,571 1.699 10 
2061291 22.58 PoT 2 1,271,382 5,050 0.397 70 
2063747 24.77 Sera 2 78,076 935 1.198 14 
2065929 26.37 Sera 10 529,728 8,033 1.516 90 
2067407 23.06 Sera 5 179,552 76,297 0.042 1,002 
2067408 24.33 Sera 5 1,135,916 66,336 5.840 634 
2067423 26.28 Serum 1 129,260 3,019 2.336 41 
2069767 24.33 PoT 2 1,124,518 22,100 1.965 287 
2070378 25.98 PoT 2 520,846 30,243 5.807 432 
2072533 26.53 Serum 1 152,588 10,736 7.036 134 
2073509 26.5 Lung 1 1,798,804 3,096 0.172 41 
2073979 18.83 Sera 10 2,090,940 92,881 4.442 749 
2075305 20.95 Lung 1 723,612 13,719 1.896 203 
2078279 18.19 Sera 5 819,850 59,698 7.282 552 
2078481 NA Serum 1 30,710 5,132 16.711 58 
2082089 19.47 Lung 1 439,064 19,620 4.469 252 
2084371 23.98 Lung 1 2,399,650 7,414 0.309 88 
2087409 20.98 Lung 1 1,172,768 4,641 0.396 61 
2087619 21.35 PoT 1 2,613,914 26,422 1.011 374 
2089141 17.89 PoT 1 6,251,778 12,888 0.206 134 
2089260 16.81 PoT 2 4,467,442 2,608 0.058 27 
2092399 19.26 Sera 2 1,170,672 2,852 0.244 29 
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2101209 23.53 Sera 3 1,550,790 8,291 0.535 85 
2101687 16.44 Sera 5 693,544 78,940 11.382 834 
2104407 13.57 Serum 1 1,933,694 9,873 0.511 106 
2104469 NA Lung 1 3,057,156 88,502 2.895 1,071 
2108625 19.89 Sera 6 1,550,226 70,296 4.535 655 
2108698 29.18 Serum 1 33,476 7,650 22.852 111 
2109640 17.7 Serum 1 794,786 9,411 1.184 71 
2125706 28.83 Oral fluid Pen* 3,372,740 3,943 0.117 55 
2132295 27.42 Serum 1 1,749,770 270,942 15.484 4,030 
2137004 29.3 Serum 1 47,964 14,201 29.608 204 
2137961 28.62 Serum 1 1,632,382 19,284 1.181 271 
2146871 24.85 Serum 1 1,613,492 191,318 11.857 2,808 
2147100 32.84 Oral fluid Pen 1,036,475 487,981 47.081 4,762 
2153073 27.93 Serum 1 485,839 46,014 9.471 443 
2154774 11.5 Serum 1 1,221,852 77,485 6.342 556 
2158115 18.77 Serum 1 395,810 1,258 0.318 13 
2158116 17.24 Serum 1 1,128,925 84,829 7.514 817 
2126306 21.35 PoT 2 2,423,832 2,376 0.098 33 
2153250 23.3 Sera 9 1,184,256 105,787 8.933 1,492 
2172065 22.1 Sera NA 748,088 79,475 10.624 1,138 
2164092 19.14 Lung 2 6,222,062 10,670 0.171 160 
2190451 26.66 Sera 5 716,850 4,584 0.639 43 
2190452 25.45 Sera 5 659,272 9,371 1.421 86 
2191288 NA Sera 10 353,150 136,394 38.622 1,517 
2206200 14.75 PoT 1 3,651,528 17,109 0.469 198 
2206201 16.51 PoT 1 2,384,358 15,394 0.646 292 
2208392 18.51 Sera 10 614,140 44,917 7.314 506 
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2210458 15.99 PoT 1 1,788,710 16,412 0.918 175 
2236039 NA Serum 1 217,310 60,139 27.674 794 
2236850 20.52 Serum 1 282,080 38,646 13.700 403 
Cq = cycle quantification; NA = not available; PoT = pool of tissues (includes mainly lungs with several other type of tissues such as 
lymph nodes, spleen, liver, intestine); PRRSV = porcine reproductive and respiratory syndrome virus; RT-qPCR = reverse-
transcription quantitative PCR; WGS = whole-genome sequencing. 
* The number of animals per pen during oral fluid sampling is unknown. 
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